Zapping dangerous heart rhythms: new tech trial
NCT ID NCT06747013
Summary
This study is testing a new medical device called the Farapoint catheter. It uses a special type of energy (pulsed field) to treat patients with specific types of dangerous, fast, or extra heartbeats (PVCs or ventricular tachycardia). The goal is to see if this procedure is safe and can successfully reduce these irregular heart rhythms for at least three months after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE VENTRICULAR CONTRACTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.